Edap Tms (EDAP) Given a $7.00 Price Target by HC Wainwright Analysts

Edap Tms (NASDAQ:EDAP) received a $7.00 target price from stock analysts at HC Wainwright in a note issued to investors on Friday, TipRanks reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. HC Wainwright’s target price suggests a potential upside of 105.28% from the company’s current price.

A number of other research analysts have also commented on the stock. TheStreet upgraded shares of Edap Tms from a “d+” rating to a “c-” rating in a research note on Thursday, February 14th. ValuEngine upgraded shares of Edap Tms from a “hold” rating to a “buy” rating in a research note on Wednesday, April 3rd. Finally, Zacks Investment Research lowered shares of Edap Tms from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 3rd.

Shares of NASDAQ EDAP traded down $0.17 during mid-day trading on Friday, reaching $3.41. 205,877 shares of the company traded hands, compared to its average volume of 201,242. Edap Tms has a fifty-two week low of $1.35 and a fifty-two week high of $5.42. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.40 and a quick ratio of 1.97. The firm has a market capitalization of $98.88 million, a PE ratio of 170.50 and a beta of 1.90.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Wednesday, May 15th. The medical equipment provider reported $0.01 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.01. Edap Tms had a negative net margin of 0.36% and a negative return on equity of 0.85%. The business had revenue of $11.50 million for the quarter, compared to analyst estimates of $13.25 million. Sell-side analysts anticipate that Edap Tms will post 0.11 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Naples Global Advisors LLC acquired a new position in Edap Tms in the fourth quarter worth approximately $31,000. Fosun International Ltd grew its position in Edap Tms by 46.0% in the fourth quarter. Fosun International Ltd now owns 249,143 shares of the medical equipment provider’s stock worth $421,000 after buying an additional 78,516 shares during the last quarter. Hilton Capital Management LLC acquired a new position in Edap Tms in the first quarter worth approximately $75,000. Finally, Commonwealth Equity Services LLC grew its position in Edap Tms by 27.0% in the first quarter. Commonwealth Equity Services LLC now owns 23,500 shares of the medical equipment provider’s stock worth $70,000 after buying an additional 5,000 shares during the last quarter. Institutional investors and hedge funds own 10.07% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Read More: FAANG Stocks

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply